It is critically important that health care professionals screen for and diagnose Alzheimer’s disease (AD) in its early stages when symptoms are subtle and resemble normal aging, as brain changes may start years before symptoms manifest and the underlying pathology evolves over decades. New care pathways are emerging to identify suitable patients for therapies that may slow disease progression, including the introduction of anti-amyloid therapies. However, care resources across communities are affected by social drivers of health, creating the need for patient-centered care modifications, and a multidisciplinary team approach (MDT), in an effort to elevate the management of AD.
In this CME Outfitters Podcast, expert faculty will discuss utilization of current and emerging screening and diagnostic tools in diverse populations for detection of AD early in the disease course; integration of culturally sensitive patient and caregiver education strategies to improve shared decision-making on brain health and/or AD management with patients; and implementation of MDT care when treating patients with AD.
At the conclusion of this activity, learners will be able to better:
This activity is supported by an educational grant from Lilly.
Neurologists, geriatricians, geriatric psychiatrists, PCPs, nurse practitioners (NPs), physician associates (PAs), nurses, and pharmacists
In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This application-based activity is approved for 1.00 contact hours (0.1 CEUs) of continuing pharmacy credit (JA0007185-0000-24-110-H01-P).
This activity is designated for 1.00 contact hours.
California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 12/31/2025. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Dr. Burke reports the following financial relationships:
Advisory Board and Consultant: Eisai and Lilly
Research Support: AbbVie; Alector; Biogen; EIP Pharma; Janssen; Lilly; and Roche
Speakers Bureau: Eisai and Lilly
Dr. Chin reports the following financial relationships:
Consultant: New Amsterdam Pharma
Stock Shareholder (directly purchased): Abbott Laboratories; AbbVie Inc.; Amgen; AstraZeneca; Biogen; CVS; Eli Lilly; Exact Sciences Corp; Gilead; Johnson & Johnson; Medtronic; and Roche Holdings
The following individuals have no financial relationships to disclose:
Rebecca Vargas-Jackson, MD (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Susan Perry (Planning Committee)
Estelle Perera (Planning Committee)
Chelsey Goins, PhD (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
Call us at 877.CME.PROS (877.263.7767).
PD-113-XXXX24-11